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Cytokine signaling is critical for proliferation, survival and differentiation of hematopoietic cell, and interleukin-3 (IL-3) is
required for maintenance of many hematopoietic cell lines, such as BaF3. We have isolated apoptosis-resistant clones of BaF3
using retroviral insertional mutagenesis and the Xbp1 locus was identiﬁed as a retroviral integration site. Expression and
splicing of the Xbp1 transcript was conserved inthe resistant clone but was promptly disappeared on IL-3 withdrawalin parental
BaF3.IL-3stimulationofBaF3cellsenhancedXbp1promoteractivityandinducedphosphorylationoftheendoplasmicreticulum
stress sensor protein IRE1, resulting in the increase in Xbp1S that activates unfolded protein response. When downstream
signaling from IL-3 was blocked by LY294002 and/or dn-Stat5, Xbp1 expression was downregulated and IRE1 phosphorylation
was suppressed. Inhibition of IL-3 signaling as well as knockdown of Xbp1-induced apoptosis in BaF3 cells. In contrast,
constitutive expression ofXbp1SprotectedBaF3fromapoptosisduring IL-3depletion.However,cell cyclearrest attheG1stage
was observed in BaF3 and myeloid differentiation was induced in IL-3-dependent 32Dcl3 cells. Expression of apoptosis-, cell
cycle- and differentiation-related genes was modulated by Xbp1S expression. These results indicate that the proper
transcriptional and splicing regulation of Xbp1 by IL-3 signaling is important in homeostasis of hematopoietic cells.
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Cytokine signaling is important for regulating cell processes in
hematopoiesis.Cytokinesbindandactivatedistinctreceptors,
anddownstreammoleculessequentiallymediateextracellular
stimulithat arerequiredforcellularsurvival,proliferationand/or
differentiation.
1 Interleukin (IL)-3 induces development of
multi-lineagecell types including granulocytes, macrophages,
erythroid cells and megakaryocytes, and it possesses abilities
to support the cellular growth and survival of more immature
cell types in vitro. IL-3 is recognized by its receptor consisting
of a- and b-subunits, and the latter is common to granulocyte-
macrophage colony-stimulating factor (GM-CSF) and IL-5
receptors.
2,3 IL-3 binding leads to hetero-dimerization and
phosphorylation of the receptor, after which downstream
molecules within the JAK/STAT, Ras/MAPK and PI3K path-
ways are activated.
2,3
IL-3 is secreted predominantly by T cells in vivo. Multiple
lineagesofhematopoieticcellsaswell asmanyleukemiccells
undergo apoptosis and growth arrest in the absence of IL-3.
4
Themembers of the Bcl2 gene family mediate the cell survival
or anti-apoptosis function under IL-3.
2,5 In fact, Bcl2 and
BclXL are rapidly induced by IL-3, which is mediated by
Jak2 activation.
6 The PI3K pathway also has a role in the
anti-apoptotic function of IL-3 via Bcl2 and Bcl2 family
member BAD.
2,5 IL-3 and GM-CSF signaling regulates BclXL
through the activation of Stat5.
7 Acquired genetic mutations
related to the IL-3 signaling pathway have also been identiﬁed
in human hematopoietic disorders. A gain-of-function muta-
tion V617F of JAK2 in human myeloproliferative neoplasm
induces constitutive phosphorylation of Stat5, resulting
in enhanced proliferation and survival of hematopoietic
precursors.
8 Genetic alterations in IL-3 signaling are thus
important for survival of malignant hematopoietic cells, and
important molecules remain to be identiﬁed in order to
understand the signaling network in the downstream of IL-3.
Retrovirus insertional mutagenesis (RIM) is a powerful tool
to identify important genes responsible for growth advantage
in clonal expansion.
9 The technique was efﬁciently utilized to
identify IL-3-independent phenotypes that could dissect the
function of particular molecules.
10 By using RIM, we have
identiﬁed Xbp1, which encodes a transcription factor impor-
tantfortheunfoldedproteinresponse(UPR)andendoplasmic
reticulum (ER) function
11,12 downstream from IL-3.
UPR is a unique signaling system associated with the ER
membrane. Any conditions inducing protein misfolding in the
ER induces UPR that attenuates translation of proteins
entering the ER.
13 UPR also activates transcription of genes
involved in the degradation of nascent misfolded proteins via
activation of IRE1, ATF4/ATF6 and Xbp1.
13 UPR induces
transcription of Xbp1 and phosphorylation of the ER trans-
membrane kinase IRE1 that initiates UPR-mediated mRNA
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www.nature.com/cddissplicing of Xbp1, resulting in the production of Xbp1S, an
active form of a basic leucine zipper transcription factor.
11,12
In this study, we demonstrate that IL-3 stimulation regulates
both transcription and splicing of Xbp1, and that Xbp1
unexpectedly affects hematopoietic cell apoptosis, growth
and differentiation. These observations reveal a novel
functional role of Xbp1 in hematopoiesis and leukemogenesis
andpossiblerelationshipbetweentheIL-3signalingandUPR.
Results
Retroviral insertional mutagenesis identiﬁed Xbp1 as a
survival factor in the IL-3-dependent BaF3 cell. BaF3
cells (3.0 10
6) were infected with the MSCV-GFP-Neo
retrovirus. The cells were incubated in the medium
containing G-418 in the absence of IL-3, 48h after
infection, and were cultured for 4 weeks to select survival
clone without IL-3. Three survival clones, B6F, B3G and
B7B, were isolated. Southern blot analysis showed clonal
integrations of the retrovirus (Figure 1a), and the retroviral
integration sites (RIS) in each clone were identiﬁed using
inverse polymerase chain reaction (IPCR) (Figure 1b). A RIS
was identiﬁed in the B6F clone at 20kb upstream of the Xbp1
gene on mouse chromosome 11 (Figure 1c), and the clone
was subjected to further investigation. Tceb1 that encodes a
15kDa subunit of transcription elongation factor B, Larp1,
a ribonucleoprotein member gene and Ptprz1, a protein
tyrosine phosphatase gene have been identiﬁed in the other
two clones.
Modulation of Xbp1 expression and splicing by IL-3
signaling. To investigate relationship between IL-3
signaling and Xbp1 expression, Xbp1 alternative splicing
that converts unstable Xbp1U to the stable form Xbp1S
was analyzed by reverse transcription (RT)-PCR (Figure 2a).
IL-3 depletion suppressed the expression of total Xbp1 and
complete disappearance of Xbp1S was observed more
rapidly than that of Xbp1U. On the other hand, B6F cells
that have MSCV integration at the Xbp1 locus showed
constitutive expression of the both Xbp1S and Xbp1U in the
absence of IL-3 (Figure 2b).
IL-3 stimulation induces Xbp1S expression and IRE1
phosphorylation. As expression and splicing of Xbp1 is
regulated by the UPR stress response system or by the ER
stress response,
11,12,14 the effect of UPR signaling on IL-3
stimulation was investigated. Removal of a 26-nucleotide
intron from Xbp1 mRNA induced by IRE1 phosphorylation
was observed 48h after addition of IL-3 to BaF3 cells
(Figure 2c), which preceded accumulation of Xbp1S protein
(Figure 2d). Modulation of IRE1 and Xbp1S production
contrasted well with rapid phosphorylation of Stat5, a direct
downstream target of IL-3 stimulation. Interestingly,
expression of cleaved ATF6 was coincided with Xbp1S
expression whereas GRP-78, another UPR marker,
15 was
not altered by IL-3 stimulation.
The ER stress response element (ERSR) within the Xbp1
promoter is responsible for the IL-3 response. As Xbp1
transcription was downregulated by IL-3 depletion, a reporter
assay was carried out using IL-3-dependent 32Dcl3 murine
myeloid cells to clarify whether the promoter activity of Xbp1
is modulated by IL-3 stimulation. The genomic region
spanning 5kb upstream of Xbp1 exon 1 was cloned into
the pGL3 basic vector. The clone’s promoter activity was
50% repressed by IL-3 deprivation or twofold activated by
IL-3 (Figure 2e). An analysis of deletion mutants revealed
that the minimal promoter activity is present within a 318-bp
region upstream from exon 1. A previous study identiﬁed an
ERSE consensus motif CCAATN9CCACG within the region
between nt  61 and  42.
11 A point mutation introduced in
this element,  59A; G, abolished the promoter activity in the
presence of IL-3 (Figure 2f), indicating that IL-3 signaling
upregulates Xbp1 transcription through ERSE.
Both PI3K and Stat5 signaling regulate the expression
of Xbp1 and PI3K controls splicing of Xbp1 under IL-3
signaling. To understand the upstream signaling network
that modulates Xbp1 transcription, PI3K and MEK path-
ways were inhibited in BaF3 cells. Xbp1 expression was
signiﬁcantly downregulated by a PI3K inhibitor LY294002 but
not by PD98059, a MEK inhibitor (Figure 3a). LY294002
treatment also suppressed proliferation of BaF3 cells
Figure 1 Retrovirus integration at the Xbp1 locus. (a) Southern blot analysis of
survival BaF3 clones in IL-3 depletion. DNA was digested with BglII or EcoRV that
cut the retrovirus once or at both long terminal repeats, respectively. The green
ﬂuorescent protein sequence was used as a probe. B6F and B3G contain a single
integration and two in B7B. (b) Retrovirus integration sites of the survival clones.
(c) A physical map of RIS at the Xbp1 locus
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Cell Death and Disease(data not shown). A reporter assay showed that LY294002
treatment downregulated the promoter activity of Xbp1
both in the 5kb fragment and in the minimal ERSE element
(Figure 3b). On the other hand, addition of PD98059 did
not show the suppressive effect and showed enhancement
of the luciferase activity in the ERSE element at least partly
due to nonspeciﬁc effect to the pGL3 promoter construct
(Figure 3b). By the western blot analysis, Xbp1S expres-
sion was downregulated by the LY294002 treatment
and IRE1 phosphorylation was inhibited, whereas Xbp1S
expression was not reduced by MEK inhibition (Figure 3c).
On the other hand, introduction of dn-Stat5 into BaF3
cells downregulated the Xbp1S expression but not IRE1
phosphorylation. These results indicate that Xbp1 expression
is regulated by both PI3K and Stat5 signaling, that PI3K
regulates Xbp1 activation by the IRE1 phosphorylation, and
that MEK signaling is dispensable for Xbp1 expression.
Downregulation of Xbp1 induces apoptosis. The efﬁcient
knockdown of Xbp1 was achieved by introducing the speciﬁc
short interference RNA (siRNA) into BaF3 cells (Figure 4a).
Apoptosis induction and reduction of viable cells was
Figure 2 IL-3 modulates Xbp1 expression and splicing. (a) An RT-PCR analysis of Xbp1. Both un-spliced and spliced forms decreased after withdrawal of IL-3. b-actin
was used to conﬁrm the quality and quantity of RNA. (b) Xbp1 expression is comparable between BaF3 with IL-3 and B6F without IL-3. (c and d) Upregulation of Xbp1S
expression by IL-3 stimulation. BaF3 cells were cultured under the IL-3-free condition for 16h. IL-3 was then added to the medium at 10ng/ml and cells were harvested after
incubation for the indicated periods. Whole cell extracts of BaF3 were subjected to RT-PCR (c) to detect Xbp1S and Xbp1U, and western blotting (d) to detect Xbp1S,
phospho-IRE1, IRE1, cleaved ATF6, phospho-Stat5, GRP78 and GAPDH. Both Xbp1S upregulation and IRE1 phosphorylation was observed at 48h after IL-3 stimulation.
(e) Genomic DNA fragments encompassing the Xbp1 upstream region indicated were subcloned into the pGL3 basic vector. The constructs were nucleofected together with
pRL-SV40 into 32Dcl3 and the cells were incubated for 24h in growth medium containing IL-3. The cells were starved for IL-3 for 24h and IL-3 was then added for additional
12h. The cells were harvested at each time point and subjected to the luciferase assay. The bars represent the means of the relative luciferase activities, which were
calculated by dividing the luciferase activity by the Renilla activity used as a transfection control. The means±S.D. from three independent experiments are shown
(**Po0.05).(f)The45ntDNAfragment(28-bpupstreamofthetranscriptionstartsiteofXbp1)thatcontainsERSE(underlined)wassubclonedintothepGL3promotervector.
The A:G mutation at nt –59 was introduced and luciferase assays were carried out in 32Dcl3 cells in the presence of IL-3. (**Po0.05)
Xbp1 in IL-3 signaling
M Kurata et al
3
Cell Death and Diseaseobserved by knockdown of Xbp1 (Figure 4b). Apoptotic
changes of BaF3 cells were associated with caspase 3
activation (Figures 4c and d). Treatment of LY294002 or
dn-Stat5 suppressed Xbp1S expression, and co-treatment
with both reagents completely abolished Xbp1S expression
with reduction of Xbp1U expression, which was exhibited
by addition of a proteasome inhibitor MG132 (Figure 4e)
Similarly, downregulation of Xbp1S induced by co-intro-
duction of LY294002 and dn-Stat5 was accompanied with
induction of apoptosis (Figure 4f). These results indicate that
Xbp1S has anti-apoptotic function and acts as downstream
from PI3K and Stat5 of IL-3 signaling.
Xbp1S partially rescues hematopoietic cells from
apoptosis by modulating expression of apoptosis-
related genes. IL-3 deprivation induces rapid growth
arrest and apoptosis of BaF3 cells. In the IL-3-free
condition, Xbp1S transfected BaF3 cells survived longer
and the number of annexin V-positive cells was reduced
compared with control vector, Xbp1U and the splice site
mutant Xbp1U532G, that is unable to synthesize the Xbp1S
form
14 (Figures 5a and b). Moreover, apoptotic induction on
LY294002 and dn-Stat5 double treatment was also inhibited
by exogenous expression of Xbp1S but not by Xbp1U and
Xbp1U532G (Figure 5c). However, the protective effects of
Xbp1S expression were incomplete and BaF3 cells failed to
survive indeﬁnitely without IL-3. The signiﬁcant phenotypic
changes of hematopoietic cells induced by Xbp1S expres-
sion suggest that there are global alterations in gene expres-
sion. RNA samples extracted from 32Dcl3 cells following
retroviral vector infection with pMIG, pMY-Xbp1U and pMY-
Xbp1S were sorted by FACS and then subjected to
expression proﬁling using the Affymetrix GeneChip micro-
array system (Affymetrix, Santa Clara, CA, USA). Statistical
comparisons identiﬁed common 1206 genes whose
expression were 42.0-fold increased, and 1663 genes
o0.5-fold in 32Dcl3-expressing Xbp1S compared with
mock-infected cells (Supplementary Tables S1, S2).
Figure 3 Xbp1 expression and activation is regulated by PI3K and Stat5 signaling. (a) Real-time PCR of Xbp1. Xbp1 expression was reduced by LY294002 treatment
(30mM)butnotPD98059(50mM)inBaF3cells(**Po0.05).(b)Luciferaseassay.SigniﬁcantrepressionofXbp1promoteractivitybyLY294002treatmentin32Dcl3cellsafter
30h exposure (**Po0.05). (c) Western blot analysis of BaF3 cells treated with PD98059 or LY294002. LY294002 treatment and dnStat5 expression downregulated Xbp1S
expression and LY294002 inhibited IRE1 phosphorylation
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Cell Death and DiseaseSub-categorization of the signiﬁcantly upregulated genes
according to Gene Ontology annotations revealed that 12
upregulated genes on Xbp1S expression were highlighted for
close association with apoptosis (Figure 5d). Modulation of
Bcl2, Bcl-g, Casp2 and Bim expression was validated by
quantitative PCR (Supplementary Figure 1). Expression of
Bim, an apoptosis facilitator under IL-3 signaling,
7 was
signiﬁcantly reduced in Xbp1S transfected cells (Figure 5e).
Upregulation of each isoforms of Bim was observed by
knockdown of Xbp1 in BaF3 cells using the Xbp1-speciﬁc
siRNA (Figure 5f).
Xbp1S modiﬁes cell cycle and differentiation.
Flowcytometric analyses revealed that Xbp1S-expressing
BaF3 cells showed 1.7-fold increase in the G1 phase
population and 40% reduction of the G2 population
(Figure 6a), indicating that constitutive expression of
Xbp1S induces cell cycle arrest at the G1 phase.
Downregulation of cell cycle-related genes was evident in
Xbp1S-expressing 32Dcl3 cells compared with those
transduced with an empty vector or Xbp1U retrovirus.
Signiﬁcant downregulation of seven cyclin genes as well as
six members of the Mcm gene family and four Cdc-related
genes was observed (Figure 6b).
Wright–Giemsa staining of cytospin samples showed
cytoplasmic azure granules and nuclear segmentation in
Xbp1S-expressing 32Dcl3 cells, typical for differentiated
granulocytes (Figure 6c). Granulocytic differentiation was
also conﬁrmed by increased MAC-1 expression in Xbp1S
transfected 32Dcl3 cells by using the ﬂowcytometric analysis
Figure 4 Xbp1 downregulation induces cell death.(a) Xbp1 knockdown with Xbp1-speciﬁc (#1 and#2) or controlsiRNAs in BaF3was conﬁrmedby western blot.(b) The
growth of cells treatedwith Xbp1-speciﬁc(#1: closed square, #2: closed circle) or control (closed triangle) siRNAs (**Po0.05). (c) Thefrequencies of annexinV-positive cells
withsiRNA(**Po0.05).(d)Cleavedcaspase3,anactiveform,wasdetectedbyXbp1knockdowninBaF3cells.(e)DownregulationofXbp1Sexpressionbydoubletreatment
of dn-Stat5 and LY294002 (30mM). Dn-Stat5 transfected GFP-positive BaF3 cells were collected by a cell sorter. At 24h after sorting, the cells were treated with LY294002.
(f) Annexin V-positive cells were detected. Signiﬁcant apoptosis induction was observed by treatment with both dn-Stat5 and LY294002 (**Po0.05)
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Cell Death and Disease(Figure 6d). Granulocytic differentiation of 32Dcl3 is induced
byG-CSFandissuppressedbyIL-3,
16suggestingthatXbp1S
may modulate the network of cytokine signaling by switching
downstream transcriptional regulation in differentiation
processes. Granulocytic differentiation of 32Dcl3 by Xbp1S
is closely correlated with upregulation of differentiation
related genes including Mef2c, Mmd2, Itgb2 (a component of
MAC-1),Ccl3,Ctsd,CtsgandCd68(Figure6c).Modulationof
Mef2c expression affects the number of myeloid progenitors
as well as granulocyte maturation,
17 suggesting that Xbp1S
regulates the Mef2c-mediated differentiation process.
A recent study showed downregulation of Mef2c by Xbp1S
on myogenic differentiation,
18 suggesting that transcriptional
regulation byXbp1S might be cell type-dependentand altered
by combination with different co-factors. Carm1 and
Ncoa2 could be such co-factors that cooperate with Mef2c
in myogenic differentiation,
19 however, these two genes
were downregulated by Xbp1S in 32Dcl3 (Supplementary
Table S2). To the contrary, the genes, such as Bmi1, Gata1,
Gata2 and Meis1 that keep the hematopoietic cells at
immature stages were downregulated by Xbp1S expression.
Modulation of the expression proﬁle by Xbp1S was validated
Figure 5 Xbp1 supports cell survival. (a) BaF3 cells were infected with pMIG (closed triangle), pMYs-Xbp1U532G (closed square), pMYs-Xbp1U (closed circle) or pMYs-
Xbp1S (open square) retroviruses and the number of cells were measured at indicated periods after incubation in the IL-3-free growth medium (**Po0.05). (b and c)
Positivities of annexin V for Xbp1-transduced BaF3 cells in IL-3-free condition (b) or treated with both LY294002 and dn-Stat5 (c). The cells were harvested 24h after IL-3
withdrawalandsubjectedto theFACSanalysis(**Po0.05).(d)Downregulated genesrelatedtoapoptosisinXbp1Stransduced32Dcl3cells.Expression wascomparedwith
pMIGorXbp1UtransducedcellsbytheAfﬁmetrixGeneChipanalysis.(e)ValidationofBimexpressionbythereal-timePCR.(f)KnockdownofXbp1inducesBimupregulation.
Each Bim isoform was detected by western blotting
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Cell Death and Diseaseby analyzing mRNA quantities of representative cell cycle-
and differentiation-related genes using quantitative PCR
(Supplementary Figure 2).
Finally, the expression proﬁling data shown here
were compared with the data from the chromatin
immunoprecipitation (ChIP)-on-chip results that exhibited
promoter binding sites of Xbp1S on particular genes
(Table 1).
18 As expected, 109 genes that were identiﬁed
in both studies were transactivated by Xbp1S, however,
19 genes were repressed, again suggesting there may be the
cell type-speciﬁc regulatory mechanism. Overall, these data
reveal the complexity of Xbp1 function in hematopoiesis and
IL-3 signaling.
Discussion
Here, we report that the IL-3 stimulates the Xbp1 by two
independent mechanisms. First, Xbp1 expression is upregu-
lated by IL-3 at the transcriptional level via PI3K and STAT5
signaling. Second, Xbp1 mRNA is spliced to convert unstable
Xbp1U to the stable form, Xbp1S, encoding a basic leucine
zipper protein that is translocated into the nucleus where it
exhibits transactivation activity. The PI3K pathway is also
important in the second mechanism. Splicing of Xbp1 is
mediatedbyphosphorylationofIRE1,aproteincomplexofER
transmembrane kinases.
11,14 The spliced form of Xbp1
mRNA is rapidly disappeared on IL-3 withdrawal, and is also
Figure 6 Xbp1S modulates cell cycle and differentiation. (a) Cell cycle arrest was induced in BaF3 cells by Xbp1S expression. Proportions of cells at G0/G1 and G2/M
phases are indicated. (b) A list of downregulated genes related to cell cycle progression in Xbp1S transduced 32Dcl3 cells. (c) Wright–Giemsa-staining of cytospin samples.
32Dcl3 cells show granulocytic differentiation by Xbp1S expression, while 32Dcl3 cells transduced with pMIG or pMYs-Xbp1U remain immature. (d) Increased intensity of
Mac-1 expression in 32Dcl3 cells by GFP-positive population with using pMY-Xbp1S-GFP vector (**Po0.05). (e) A list of upregulated genes associated with myeloid cell
differentiation
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Cell Death and Diseasedecreased by the treatment with a PI3K inhibitor, LY294002.
Inhibition of both PI3K and STAT5 pathways suppressed
Xbp1S expression and apoptosis induction, suggesting that
Xbp1 has the important role of anti-apoptotic factor in the IL-3
signaling. Upregulation of Xbp1 transcription by IL-3 signaling
is mediated through ERSE in the promoter region. Previous
studies reported that Xbp1 expression is regulated by Xbp1
itself, and by Atf6, both of which bind to the ERSE.
12,14
However, upregulationof Xbp1 promoteractivityismore rapid
than production of Xbp1S (Figures 2b-d). Moreover, Atf6 is
upregulated by Xbp1S as shown in the current gene
expression proﬁle. These results suggest that there may be
additional network of transcription factors governed by IL-3
and PI3K signaling, which regulates the Xbp1 promoter.
The knockdown of Xbp1-induced growth suppression
and caspase 3-dependent apoptosis in BaF3, indicating its
important role in cell survival. Introduction of Xbp1S cDNA
indeed rescued BaF3 cells from apoptosis and growth
suppression mediated IL-3 withdrawal. In addition, the anti-
apoptotic effect of Xbp1 was abrogated by the splice site
mutation, suggesting that Xbp1 might support cell survival
using its transactivation activity and suppressing apoptosis
activators, such as Bim.
8 It should be noted that the enhanced
UPR such as increased IRE1 activity protects cell from
apoptosis.
20 However, the effect was incomplete and BaF3,
which overexpressed Xbp1S failed to grow without IL-3.
Constitutive expression of Xbp1S unexpectedly induced
cell cycle arrest in BaF3 cells and cellular differentiation in
32Dcl3 myeloid precursor cells. Xbp1S expression is strongly
stimulated after re-activation by IL-3 and it declines to the
steady-statelevelwhenIL-3isabundant(Figure2c).Although
theIL-3stimulusactivatesXbp1promoteractivity,onlyXbp1S
possesses a transactivation domain and has a longer half-life
than Xbp1U.
21 Since neither growth suppression nor differ-
entiation induction was observed by Xbp1U introduction,
constitutive expression of Xbp1S could affect homeostasis of
hematopoietic cells. When Xbp1S was expressed under the
control of the immunoglobulin VH promoter/Em enhancer in a
transgenic mouse model, the mice developed multiple
myeloma.
22 Upregulated expression of XBP1S was also
noted in human cases of multiple myeloma,
22 suggesting
different actions of Xbp1S in hematopoietic precursors and
plasma cells. Indeed, Xbp1S is induced by plasma cell
differentiation and IgM heavy chain production in B cells.
23
Xbp1S also induces IL-6 secretion in B cells, however, IL-6
expression was decreased in 32Dcl3 cells, again suggesting
different behavior of Xbp1S between hematopoietic precur-
sors and differentiated B-lineage cells.
Cytokine-induced expression of Xbp1 has also been
reported in case of IL-4 treatment of B cells.
23 Although both
IL-3 and IL-4 enhance transcription and splicing of Xbp1,
inductionbyIL-4ismorerapidthanbyIL-3andupregulationof
GRP78 is observed in the presence of IL-4 but not in IL-3.
Perhaps IRE1 phosphorylation is directly downstream from
IL-4signaling whereas PI3Kand STAT5 signaling is mediated
after cellular stimulation by IL-3. Additional studies will be
needed to address the question.
Global and extensive modiﬁcation of gene expression by
Xbp1S in 32Dcl3 was observed as expected from gross
phenotypic changes. Combining data from our expression
proﬁling and genome-wide ChIP is useful to understand the
generegulatorynetworkmodulatedbyXbp1Sassummarized
inTable1.Itislikelythatmostofthesegenesaredirecttargets
of Xbp1S, and many UPR-inducible genes are included in the
list. In contrast, the genes related to differentiation, cell cycle
progression and apoptotic function are not included, suggest-
ing that these biological processes may be induced as an
indirect consequences of UPR. In summary, these studies
identify a close relationship between the cytokine signaling
system and UPR, and the important role of Xbp1 in
hematopoietic cell homeostasis as well as leukemogenic
process.
Materials and Methods
Cell culture and treatment. BaF3 and 32Dcl3, were maintained with
10ng/mlof IL-3(R& DSystems,Minneapolis, MN,USA)asdescribedpreviously.
16
IL-3 signaling inhibitor, PD98059 (Cell Signaling Technologies, Beverly, MA, USA)
and LY294002 (Sigma, St. Louis, MO, USA) were used at the 50mM and 30mM,
respectively.
Retrovirus infection and selection of survival clones under
IL-3-free condition. The MSCV-GFP-Neo retroviral vector is composed of
enhanced green ﬂuorescent protein (EGFP) and neomycin resistance genes
ﬂanked with MSCV long terminal repeats. The plasmid was transfected to Plat-E
packaging cells (a gift from Dr. Toshio Kitamura) using lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) according to the manufacture’s protocol. In all,
3 10
6 BaF3 cells were added with retroviral stock with 6mg/ml of polybrene
(Sigma) and spun at 1400 g for 2h. After 24h, cells were seeded into 96-well
plates at 1 10
4 cells per well in G418-containing growth medium without IL-3.
Isolation of RISs. RISs were identiﬁed using the IPCR approach as described
previously.
24 Brieﬂy, genomic DNA was digested with EcoRI, BamHI, BglII, NcoI,
HindIII or SacI, self-ligated, and subjected to nested IPCR. The PCR primers for
each restriction digestion are available on request. The PCR products were
Table 1 Genes detected by the current expression proﬁling and ChIP-on-chip assay by Acosta-Alvear et al
18
Upregulated genes
Alg12, Ap3m1, Apba3, Arcn1, Arf4, Arﬁp2, Asb3, Bet1, Bet1l, Cd68, Cdk2ap2, Cdk5rap3, Cdk7, Copa, Copb2, Copg, Creb3l2, Creld2, Dad1,
Ddit3, Derl1, Dhdds, Dnajb9, Dnajb11, Dnpep, Edem1, Edem2, Eif2ak3, Elovl2, Entpd7, Eny2, Ero1lb, Fam18b, Fkbp2, Gabarap, Gdap2, Ggcx,
Gla, Gle1l, Golga1, Golga3, Gys1, H13, H47, Hbp1, Hdldp, Herpud1, Hist1h2ad, Hmbox1, Ift20, Impdh1, Isg20, Kbtbd3, Lman2, Lrrc59, Mbnl2,
Mdh1, Mef2c, Napa, Nbr1, Ncstn, Nfxl1, Oat, P4hb, Pde4dip, Pdia3, Pdia6, Pecr, Pgm3, Pla2g6, Polr3k, Ppib, Ppp1r10, Prdx6, Preb, Rpn1,
Sar1a, Sec13l1, Sec23b, Sec24d, Sec63, Selm, Slc2a6, Slc30a5, Slc30a7, Spcs2, Srp19, Srp54b, Srpr, Srprb, Ssr2, Ssr3, Stch, Stt3a, Stx5a,
Stx18, Tbc1d15, Tipf5, Tme3, Tmem39a, Tmem167b, Tnfaip1, Txndc4, Txndc11, Ube1dc1, Ufd1l, Ufm1, Yipf2, Zfand2a
Downregulated genes
Aasdhppt, Brca1, Cdca8, Eif1a, H2afx, Hnrpa3, Hs2st1, Khsrp, Kif18a, Marcks, Mastl, Ncapd2, Osgep, Rapsn, Ric8b, Rrm2b, Sdccag8, Txnl1,
Zfp473
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plasmid (Promega, Madison, WI, USA), and subjected to sequence analysis.
Southernblotanalysis. Southernblot analysiswas carriedoutto assessthe
clonal insertion of the retrovirus. The genomic DNA was digested with appropriate
restriction enzymes, subjected to agarose gel electrophoresis and transferred to
Hybond-N nylon ﬁlter (GE Healthcare, Little Chalfont, UK) the ﬁlter was hybridized
with the GFP sequence as a probe.
RT-PCR. The splicing of Xbp1 was detected by RT-PCR using (Promega) and
Expand High Fidelity PCR System (Roche, Basel, Switzerland) using the Xbp1
362F (50-TAACGGGAGAAAACTCACGGC-30) and Xbp1 1017R (50-CAGA
CAATGGCTGGATGAAAGC-30) primers. PCR products were digested by PstIt o
differentiate Xbp1U from Xbp1S,
25 separated by electrophoresis on 2% agarose
gels and visualized by ethidium bromide staining.
Western blot analysis. Western blot analysis was performed using total
cell lysates as described previously.
26 Primary antibodies used were anti-GAPDH,
anti-Xbp1, anti-GRP78, anti-IRE1, anti-ATF6, anti-caspase 3 (Santa Cruz Biotech,
Santa Cruz, CA, USA), anti-phospho-IRE1 (Novus Biologicals, Littleton, CO, USA),
anti-phospho-Stat5, anti-Akt, anti-phospho-Ser473-Akt, anti-Erk and phospho-Erk
(Cell Signaling Technologies), anti-Bim (Pharmingen, San Diego, CA, USA).
Secondary anti-rat, rabbit, and anti-mouse IgG antibodies were purchased from GE
Healthcare. For detection to Xbp1U, cells were treated with 10mM MG132 (Sigma)
for 2h as indicated.
14
Luciferaseassay. GenomicDNAfragmentsoftheXbp1promoterregionwere
ampliﬁed by PCR using a mouse BAC clone as a template and subcloned into the
pGL3 basic or pGL3 promoter vectors (Promega). To induce point mutations within
IL-3-responsive element, the fragment was ampliﬁed by using speciﬁc primers,
–59G (50-TGCTAGCGAGCACCGGCCGATCGCGGAC-30) within ERSE. In all,
1mgofthereporterplasmidtogetherwith50ngofpRL-SV40wereintroducedintoa
total of 1 10
6 32Dcl3 cells by using Nucleofector device and solution V (Lonza,
Cologne, Germany). Luciferase activities were measured using the Dual-Luciferase
Reporter Assay System (Promega) and Lumat LB9507 (Perkin Elmer, Waltham,
MA, USA).
siRNA and retroviral vector infection. In all, 2mg of siRNA for Xbp1
purchased from QIAGEN (Hilden, Germany) was introduced into BaF3. Entire
coding regions of Xbp1S and Xbp1U were ampliﬁed and FLAG-tagged by RT-PCR,
and subcloned into the pMYs-IRES-GFP retroviral vector (a gift from Toshio
Kitamura). To induce point mutations within Xbp1U was ampliﬁed by using
speciﬁc primer 532G (50-CCAGCAGGTGCAGGCCCAGTTGTC-30). To inhibit IL-3
signaling, pMYs-dn-Stat5-IRES-GFP was used (a gift from Toshio Kitamura).
Infection efﬁciency was determined by measuring GFP-positive cells using
FACScalibur ﬂow cytometer (Becton Dickinson, Franklin Lakes, NJ, USA).
Cell cycle assay, ﬂow cytometer and apoptosis assay. Single cell
suspensions were permeabilized with 0.1% triton X-100 in PBS, and 50mg/ml
propidiumiodideand1mg/mlRNAseAwasadded.Thecellsuspensionswerethen
analyzed by using a FACScalibur ﬂow cytometer (Beckton Dickinson) and Modiﬁt
software (Becton Dickinson). For the surface marker analysis, suspensions of
1 10
6 cells were incubated with ﬂuoresceinisothiocyanate-conjugated anti-Mac-1
(Pharmingen) for 30m, washedthree times in PBS, applied to a ﬂow cytometerand
ﬂuorescence intensity of GFP-positive population was detected. Apoptosis assays
were performed using annexin V–PE apoptosis detection kit I (Pharmingen)
according to the manufacturer’s protocol.
Array hybridization. The mouse Genome 430 2.0 Array was hybridized with
cRNA probes generated from Xbp1-expressing 32Dcl3 cells. Arrays were scanned
using an Affymetrix confocal scanner and analyzed using Affymetrix Gene Chip
Command Console Software (AGCC, Affymetrix) and GeneSpring (Agilent
Technologies, Santa Clara, CA, USA) as described previously.
26,27
Statistical analysis. Results were evaluated statistically by using Student’s
t-test. A value of Po0.05 was considered signiﬁcant.
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